AU2002211427A1 - Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors - Google Patents
Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitorsInfo
- Publication number
- AU2002211427A1 AU2002211427A1 AU2002211427A AU1142702A AU2002211427A1 AU 2002211427 A1 AU2002211427 A1 AU 2002211427A1 AU 2002211427 A AU2002211427 A AU 2002211427A AU 1142702 A AU1142702 A AU 1142702A AU 2002211427 A1 AU2002211427 A1 AU 2002211427A1
- Authority
- AU
- Australia
- Prior art keywords
- inhibitors
- effects
- signal transduction
- combined administration
- farnesyl transferase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23824000P | 2000-10-05 | 2000-10-05 | |
US60/238,240 | 2000-10-05 | ||
US23881300P | 2000-10-06 | 2000-10-06 | |
US60/238,813 | 2000-10-06 | ||
PCT/US2001/031104 WO2002028409A2 (en) | 2000-10-05 | 2001-10-04 | Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002211427A1 true AU2002211427A1 (en) | 2002-04-15 |
Family
ID=26931459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002211427A Abandoned AU2002211427A1 (en) | 2000-10-05 | 2001-10-04 | Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors |
Country Status (3)
Country | Link |
---|---|
US (2) | US20020077301A1 (en) |
AU (1) | AU2002211427A1 (en) |
WO (1) | WO2002028409A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2424797C (en) * | 2000-10-05 | 2009-12-29 | George Q. Daley | Methods of inducing cancer cell death and tumor regression |
EP2253319A1 (en) * | 2001-05-16 | 2010-11-24 | Novartis AG | Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent. |
EP1704863A3 (en) * | 2001-05-16 | 2010-11-24 | Novartis AG | Combination comprising N-5-4-(4-Methyl-Piperazino-Methyl-)Benzoyla Mido]-2-Methylphenyl -4-(3-Pyridyl)-2Phyrimidine-amine and a chemotherapeutic agent |
WO2003000186A2 (en) | 2001-06-21 | 2003-01-03 | Ariad Pharmaceuticals, Inc. | Novel phenylamino-pyrimidines and uses thereof |
EP1487452B1 (en) * | 2002-02-22 | 2006-05-24 | The Government of the United States of America, as represented by The Department of Veterans Affairs | Use of 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl -benzamide for treating seminomas |
US20030211461A1 (en) * | 2002-05-01 | 2003-11-13 | Genoptix, Inc | Optophoretic detection of durgs exhibiting inhibitory effect on Bcr-Abl positive tumor cells |
EP1613308A4 (en) * | 2003-03-27 | 2008-02-20 | Lankenau Inst Medical Res | Novel methods for the treatment of cancer |
TW200526215A (en) * | 2003-11-06 | 2005-08-16 | Schering Corp | Method of treating breast cancer |
US20070293539A1 (en) * | 2004-03-18 | 2007-12-20 | Lansbury Peter T | Methods for the treatment of synucleinopathies |
WO2005089518A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Uch-l1 expression and cancer therapy |
US20050272722A1 (en) * | 2004-03-18 | 2005-12-08 | The Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
EP1744751A4 (en) * | 2004-03-18 | 2010-03-10 | Brigham & Womens Hospital | Methods for the treatment of synucleinopathies |
US20060194821A1 (en) * | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
WO2007042465A2 (en) * | 2005-10-07 | 2007-04-19 | Novartis Ag | Combinati0n of nilotinib with farnesyl transferase inhibitors |
EP1945182B1 (en) * | 2005-10-14 | 2010-07-28 | Janssen Pharmaceutica N.V. | Formulations of tipifarnib for intravenous application |
WO2009151683A2 (en) * | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
US20100331363A1 (en) * | 2008-11-13 | 2010-12-30 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
BRPI0920927A2 (en) * | 2008-11-13 | 2019-09-24 | Link Medicine Corp | azaquinolinone derivatives and uses thereof |
US20110060005A1 (en) * | 2008-11-13 | 2011-03-10 | Link Medicine Corporation | Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
US20130302644A1 (en) * | 2009-02-20 | 2013-11-14 | Nucor Corporation | Hot rolled thin cast strip product and method for making the same |
RU2487961C2 (en) * | 2011-10-24 | 2013-07-20 | Открытое акционерное общество "Раменское приборостроительное конструкторское бюро" (ОАО "РПКБ") | Method of quenching blanks from d16 aluminium alloy |
EP2976085A1 (en) | 2013-03-21 | 2016-01-27 | INSERM - Institut National de la Santé et de la Recherche Médicale | Method and pharmaceutical composition for use in the treatment of chronic liver diseases associated with a low hepcidin expression |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997045412A1 (en) * | 1996-05-30 | 1997-12-04 | Merck & Co., Inc. | A method of treating cancer |
JP2002510308A (en) * | 1997-06-17 | 2002-04-02 | シェーリング コーポレイション | Benzo (5,6) cyclohepta (1,2-B) pyridine derivatives as farnesyl protein transferase inhibitors |
WO1998057948A1 (en) * | 1997-06-17 | 1998-12-23 | Schering Corporation | Novel n-substituted urea inhibitors of farnesyl-protein transferase |
US6004558A (en) * | 1998-02-25 | 1999-12-21 | Novogen, Inc. | Methods for treating cancer with legume plant extracts |
US20010039952A1 (en) * | 1998-11-10 | 2001-11-15 | Walter A. Hacker, Ph. D | Ultrasound enhanced chemotherapy |
JP4876239B2 (en) * | 1999-01-11 | 2012-02-15 | プリンストン ユニバーシティー | High affinity inhibitors for target confirmation and use thereof |
US6245759B1 (en) * | 1999-03-11 | 2001-06-12 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
US6316462B1 (en) * | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
US20030022918A1 (en) * | 2000-02-29 | 2003-01-30 | Horak Ivan David | Farnesyl protein transferase inhibitor combinations with an her2 antibody |
US20020061304A1 (en) * | 2000-03-20 | 2002-05-23 | Pfizer Products Inc. & Osi Pharmaceuticals, Inc. | Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
TWI310684B (en) * | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
US20030229099A1 (en) * | 2000-08-30 | 2003-12-11 | Zhu Hugh Y. | Novel farnesyl protein transferase inhibitors as antitumor agents |
CA2424797C (en) * | 2000-10-05 | 2009-12-29 | George Q. Daley | Methods of inducing cancer cell death and tumor regression |
-
2001
- 2001-10-04 US US09/971,365 patent/US20020077301A1/en not_active Abandoned
- 2001-10-04 WO PCT/US2001/031104 patent/WO2002028409A2/en active Application Filing
- 2001-10-04 AU AU2002211427A patent/AU2002211427A1/en not_active Abandoned
-
2004
- 2004-06-17 US US10/870,403 patent/US20050020516A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20050020516A1 (en) | 2005-01-27 |
WO2002028409A3 (en) | 2003-03-06 |
US20020077301A1 (en) | 2002-06-20 |
WO2002028409A2 (en) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002211427A1 (en) | Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors | |
AU5772698A (en) | Inhibitors of farnesyl protein transferase | |
AU2001243158A1 (en) | Inhibitors of prenyl-protein transferase | |
AU2136697A (en) | Inhibitors of farnesyl protein transferase | |
AU3880897A (en) | Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase | |
AU2002213485A1 (en) | Inhibitors of protein kinases | |
IL133470A0 (en) | Inhibitors of farnesyl protein transferase and pharmaceutical compositions containing same | |
AU2710597A (en) | Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors | |
IL140328A0 (en) | Inhibitors of transcription factor nf-kb | |
AU7167298A (en) | Inhibitors of the jnk signal transduction pathway and methods of use | |
EP1324985A4 (en) | Inhibitors of prenyl-protein transferase | |
EP1027042A4 (en) | Inhibitors of farnesyl protein transferase | |
AU2001238217A1 (en) | Inhibitors of prenyl-protein transferase | |
AU2001247197A1 (en) | Inhibitors of prenyl-protein transferase | |
AU2001253197A1 (en) | Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase | |
AU2001252147A1 (en) | Farnesyl protein transferase inhibitor combinations | |
AU2477400A (en) | Inhibitors of prenyl-protein transferase | |
AU7354900A (en) | Inhibitors of prenyl-protein transferase | |
AU5164898A (en) | Thioproline-containing inhibitors of farnesyl protein transferase | |
AU2001227757A1 (en) | Inhibitors of prenyl-protein transferase | |
AU2001238424A1 (en) | Inhibitors of prenyl-protein transferase | |
AU2274101A (en) | Inhibitors of prenyl-protein transferase | |
AU2001230864A1 (en) | Inhibitors of prenyl-protein transferase | |
HUP9904056A3 (en) | Substituted benzocycloheptapyridine derivatives useful as inhibitor of farnesyl protein transferase and use thereof | |
AU6678398A (en) | Inhibitors of isoprenyl transferase |